Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-01-18 @ 6:47 PM
Study NCT ID:
NCT05819359
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-10
First Post:
2023-04-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Sponsor:
Bial R&D Investments, S.A.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Parkinson's Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Parkinson Disease | View |
| None | Neurodegenerative Diseases | View |
| None | Central Nervous System Diseases | View |
| None | Glucocerebrosidase (GCase) activity | View |
| None | Parkinsonian Disorders | View |
| None | Basal Ganglia Diseases | View |
| None | Movement Disorders | View |
| None | GBA1 gene | View |
| None | BIA 28-6156 | View |
| None | Phase 2 | View |